Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.40
-0.29 (-4.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.42
+0.02 (0.31%)
After-hours: Dec 5, 2025, 7:41 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $413.25 million as of December 5, 2025. Its market cap has increased by 639.38% in one year.
Market Cap
413.25M
Enterprise Value
189.60M
1-Year Change
639.38%
Ranking
Category
Stock Price
$6.40
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has increased from $365.84M to $413.25M, an increase of 12.96%. That is a compound annual growth rate of 2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 431.97M | 532.36% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |